In 2018, following a protracted process, the Public Health (Alcohol) Act was enacted to address alcohol use and associated harm in Ireland. The Act includes legislation restricting alcohol availability, advertising and promotion, sales and pricing: it aims to reduce population-level alcohol use and related harm but particularly to delay or prevent alcohol use among children and young people.¹

The Tabor Group is a provider of residential addiction treatment services in Ireland. It aims to offer hope, healing, and recovery to clients suffering from addictions through integrated and caring services. In addition to two residential facilities, the organisation provides a continuing care programme to clients who have completed treatment in order to assist with their recovery as well as a community-based programme. Its family support programme offers counselling to families whose loved ones are struggling with an addiction. In 2022, the Tabor Group published its annual report for 2021.¹ This article highlights services provided by the Tabor Group to individuals with a substance use addiction in 2021.

Coolmine Therapeutic Community is a drug and alcohol treatment centre providing community, day, and residential services to men and women with problematic substance use and to their families in Ireland. Established in 1973, Coolmine was founded on the philosophies of the therapeutic community approach to addiction treatment. This is primarily a self-help approach in which residents are responsible for their own recovery, with peers and staff acting as facilitators of change. Participants are expected to contribute to the general running of the community and to their own recovery by actively participating in educational activities and in group and individual therapy. This article highlights services provided by Coolmine in 2020.¹

UISCE, the Union for Improved Services, Communication and Education for people who use drugs (PWUD), published its new strategy in July 2022 entitled Peer partnership for change: UISCE’s strategy to build inclusion and participation of people who use drugs 2022–2025.¹